跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 671 条关于
“arrhythmogenic substrate”
全部
671
临床试验
513
药物
18
机构
1
资讯
139
5个月前
Catheter Precision Presents New Clinical Data for VIVO and LockeT Systems at Heart Rhythm Society Meeting
6个月前
Shionogi Initiates Phase 2 Trial for First Oral Substrate Reduction Therapy in Late-Onset Pompe Disease
去年
Promega Secures Patent Victory Against Aobious in Luciferase Technology Dispute
9个月前
Tenaya Therapeutics Reports Positive Gene Therapy Data for Rare Heart Disease Despite Stock Decline Following $60M Offering
去年
AMO Pharma Launches Largest-Ever Clinical Trial for Rare Heart Condition ARVC with GSK3β Inhibitor AMO-02
8个月前
Lucerastat Demonstrates Significant Efficacy in Phase 3 Trial for Fabry Disease Treatment
去年
AceLink's Oral GCS Inhibitor Shows Promising Phase 2 Results in Fabry Disease Treatment
8个月前
Lexeo Therapeutics Reports Promising Phase I/II Data for Gene Therapy LX2020 in Rare Heart Disease
去年
Lexeo Therapeutics to Showcase Advanced AAV Manufacturing Platform at ASGCT Annual Meeting
7个月前
Gene Therapy Targeting Connexin-43 Shows Promise for Treating Inherited Heart Disease in Young Athletes
第 1 页,共 14 页
上一页
下一页